MedTrace Logo

Fecal Transplant in Recurrent Hepatic Encephalopathy

NCT02636647 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-07-05

No results posted yet for this study

Summary

Randomized, open-label safety, tolerability study with exploratory endpoints and pathophysiological evaluation of the FMT

Two groups of outpatients with cirrhosis will be randomized using random sequence generator into no-treatment and FMT groups.

Conditions

  • Hepatic Encephalopathy
  • Cirrhosis

Interventions

BIOLOGICAL

Fecal transplant

Sponsors & Collaborators

  • OpenBiome

    collaborator INDUSTRY

  • Jasmohan Bajaj

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02636647 on ClinicalTrials.gov